News articles about UnitedHealth Group (NYSE:UNH) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. UnitedHealth Group earned a coverage optimism score of 0.20 on Accern’s scale. Accern also assigned media headlines about the healthcare conglomerate an impact score of 46.4325879292821 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Here are some of the news stories that may have impacted Accern Sentiment’s rankings:
- ValuEngine Lowers UnitedHealth Group (UNH) to Hold (americanbankingnews.com)
- A.M. Best Comments on Credit Ratings of UnitedHealth Group Incorporated & Its Subsidiaries Following Announcement of Acquisit… (ih.advfn.com)
- UnitedHealthcare Awards $10,000 to Digital Hyve for Innovative Project to Improve Health and Wellness in Central New York (finance.yahoo.com)
- DaVita Inc. — Moody’s affirms DaVita’s Ba2 CFR; outlook stable (finance.yahoo.com)
- The Hot Stock: DaVita Got How Much From UnitedHealth?!?! (finance.yahoo.com)
Several brokerages have issued reports on UNH. Jefferies Group reaffirmed a “buy” rating and set a $248.00 price target on shares of UnitedHealth Group in a report on Friday, December 1st. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a report on Friday, December 1st. Sanford C. Bernstein raised their price target on UnitedHealth Group from $219.00 to $246.00 and gave the company an “outperform” rating in a report on Friday, December 1st. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Raymond James Financial reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Wednesday. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $224.56.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same quarter last year, the firm earned $2.17 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. sell-side analysts expect that UnitedHealth Group will post 9.99 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is currently 33.26%.
In related news, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the transaction, the insider now owns 195,625 shares in the company, valued at $38,755,268.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Michele J. Hooper sold 5,000 shares of the firm’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $222.20, for a total value of $1,111,000.00. Following the completion of the transaction, the director now owns 36,989 shares in the company, valued at approximately $8,218,955.80. The disclosure for this sale can be found here. Insiders have sold 62,606 shares of company stock valued at $12,677,525 in the last three months. Insiders own 0.89% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.